Impact of improved classification on the association of human papillomavirus with cervical precancer.
about
Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, IndiaHuman papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions3q26 amplification is an effective negative triage test for LSIL: a historical prospective studyUsing biomarkers as objective standards in the diagnosis of cervical biopsies.Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3Next Generation Cancer Protection: The Bivalent HPV Vaccine for FemalesThe detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.HPV vaccines and cancer prevention, science versus activism.Commercially available assays for multiplex detection of alpha human papillomaviruses.Cytology versus HPV testing for cervical cancer screening in the general population.Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.Immunohistochemical expression of p16 and HPV L1 capsid proteins as predictive markers in cervical lesions.HPV L1 capsid protein expression in squamous intraepithelial lesions of cervix uteri and its relevance to disease outcome.
P2860
Q21136074-0AC81861-E29C-44C0-9152-EBF36B4B7064Q24198236-7430611B-163F-42E5-91EA-58C49995E67AQ28727452-D56C2EC2-9BE8-4267-9BFF-65DA7399D33FQ30431203-72FDE13D-0713-4CF7-9E86-0590801C12A4Q33883585-D9DCB1EE-4F0E-4D3F-A1C4-D963FAE59553Q33984185-865C0019-2F76-4EB1-9D93-291CEEAB1103Q35550810-2F0CE57A-6748-4D7C-96DF-452766EEDE27Q36360128-E38CE197-107D-4899-AEDE-C5301D47B3F6Q36591743-73232DBA-FBAE-44E3-AE7A-5EBBA4700A83Q37800921-8D092B63-6697-458A-8749-87572F751F12Q38630360-CA84AC6B-6910-4C8F-BE5E-02088FF7985EQ42209186-A8BED5D6-4235-45D0-BAF9-778C595F81CBQ42248567-9E5DFE75-BE61-4C3F-9B1C-EA9932508C7FQ43710001-8B0B6985-7844-4583-A111-4C8C75D78726
P2860
Impact of improved classification on the association of human papillomavirus with cervical precancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Impact of improved classificat ...... virus with cervical precancer.
@ast
Impact of improved classificat ...... virus with cervical precancer.
@en
type
label
Impact of improved classificat ...... virus with cervical precancer.
@ast
Impact of improved classificat ...... virus with cervical precancer.
@en
prefLabel
Impact of improved classificat ...... virus with cervical precancer.
@ast
Impact of improved classificat ...... virus with cervical precancer.
@en
P2860
P50
P356
P1476
Impact of improved classificat ...... virus with cervical precancer.
@en
P2093
Patti E Gravitt
Philip E Castle
P2860
P304
P356
10.1093/AJE/KWP390
P407
P577
2009-12-10T00:00:00Z